Mural Oncology (MURA) News Today $1.59 -0.09 (-5.36%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$1.62 +0.03 (+2.20%) As of 08/8/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MURA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Colourful mural celebrates 10 years of cancer care at WWLAugust 4, 2025 | msn.comMural Oncology Announces Second Quarter Financial Results and Provides Business UpdateAugust 4, 2025 | globenewswire.comMural Oncology (NASDAQ:MURA) Stock Rating Upgraded by Wall Street ZenAugust 4, 2025 | americanbankingnews.comArtists help pupils and centre users create muralsAugust 3, 2025 | msn.comBaltimore honors Henrietta Lacks with community-painted muralAugust 2, 2025 | msn.comDowntown Raleigh’s history unfolds in a sprawling new mural. Who is on it?July 28, 2025 | msn.comNew mural inspires student growth on the Eastern ShoreJuly 28, 2025 | msn.comCan Mural Oncology (NASDAQ:MURA) Afford To Invest In Growth?July 23, 2025 | finance.yahoo.comMinneapolis muralist honors Tuskegee airmenJuly 19, 2025 | msn.comMural Oncology, Inc.: Mural Oncology Announces Fourth Quarter and Year End 2024 Financial Results and Highlights Upcoming Clinical Milestones - FinanzNachrichten.deJuly 8, 2025 | finanznachrichten.deBuilding that features the PINK of Terre Haute wings mural to be demolishedJuly 4, 2025 | msn.com'Vibrancy': New murals proposed for Downtown Peoria parking decksJuly 3, 2025 | msn.comForm 8.3 - The Vanguard Group, Inc.: Mural Oncology plcJune 16, 2025 | markets.businessinsider.comBlackRock discloses 1.64% stake in Mural OncologyJune 13, 2025 | investing.comForm 8.3 - The Vanguard Group, Inc.: Mural Oncology plcJune 13, 2025 | markets.businessinsider.comBlackRock discloses 1.39% stake in Mural OncologyJune 12, 2025 | investing.comBlackRock Reveals 1.58% Holding in Mural OncologyJune 5, 2025 | msn.comGoldman Sachs adjusts positions in Mural OncologyMay 21, 2025 | investing.comMural Oncology Announces Number of Relevant Securities in IssueMay 19, 2025 | globenewswire.comBlackRock discloses stake in Mural Oncology plcMay 15, 2025 | investing.comBlackRock discloses stake in Mural OncologyMay 3, 2025 | investing.comGoldman Sachs discloses stake in Mural OncologyMay 3, 2025 | investing.comFORM 8.1(a) & (b) - Mural Oncology plcApril 30, 2025 | globenewswire.com‘Final mark on his legacy’: Wood County artists dedicate work to muralist who died in JanuaryApril 29, 2025 | msn.comLuka Dončić donates entire cost of restoring vandalized Kobe Bryant mural in downtown Los AngelesApril 29, 2025 | msn.comParkwood Master Fund Ltd - Form 8.3 - Mural Oncology PlcApril 24, 2025 | uk.finance.yahoo.comForm 8.3 - Mural Oncology plcApril 22, 2025 | finance.yahoo.comBoston-area cancer research lab to cease drug trials, lay off 117April 22, 2025 | msn.comMass. biotech company cuts 90% of workforceApril 17, 2025 | msn.comForm 8.3 - The Vanguard Group, Inc.: Mural Oncology plcApril 17, 2025 | markets.businessinsider.comMural Oncology to discontinue nemvaleukin development, reduce staff by 90%April 16, 2025 | markets.businessinsider.comMural shuts down lead programme and slashes 90% of staffApril 16, 2025 | finance.yahoo.comBiotech Company Sees Stock Boost Following Major Strategy ShiftApril 15, 2025 | msn.comMural Oncology to Explore Options, Cut 90% of WorkforceApril 15, 2025 | marketwatch.comMural Oncology cuts 90% of staff, pulls plug on cancer drugApril 15, 2025 | bizjournals.comMural Oncology Shares Surge As Company Explores Strategic Alternatives: What's Going On?April 15, 2025 | benzinga.comMural Oncology Announces Plans to Explore Strategic AlternativesApril 15, 2025 | globenewswire.comMural Oncology: Phase 3 Clinical Trial Setback Undermines Company's Future ProspectsMarch 28, 2025 | seekingalpha.comPetri Dish: Late-stage cancer trial halt; Dyne names CFOMarch 27, 2025 | bizjournals.comMural Oncology price target lowered to $6 from $18 at H.C. WainwrightMarch 27, 2025 | markets.businessinsider.comMural Oncology downgraded to Outperform from Strong Buy at Raymond JamesMarch 26, 2025 | markets.businessinsider.comMural Oncology (NASDAQ:MURA) Receives Hold Rating from Jones TradingMarch 26, 2025 | marketbeat.comRaymond James downgrades Mural Oncology after ovarian cancer failureMarch 26, 2025 | markets.businessinsider.comMural Oncology halting progress of nemvaleukin trial in ovarian cancerMarch 26, 2025 | markets.businessinsider.comJones Trading Downgrades Mural Oncology (MURA)March 25, 2025 | msn.comMural Oncology to Discontinue Ovarian Cancer Drug Candidate as Trial Misses TargetsMarch 25, 2025 | marketwatch.comAlkermes spinoff Mural plunges on plans to halt ovarian cancer trialMarch 25, 2025 | msn.comMural Oncology’s Phase III ovarian cancer trial failure knocks stock by 57%March 25, 2025 | finance.yahoo.comMural Oncology's Ovarian Cancer Combo Drug Trial Disappoints, Stock PlungesMarch 25, 2025 | benzinga.comMural Oncology Provides Update on Phase 3 ARTISTRY-7 Trial of Nemvaleukin in Combination with KEYTRUDA® (pembrolizumab) in Patients with Platinum-Resistant Ovarian CancerMarch 25, 2025 | globenewswire.com Get Mural Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for MURA and its competitors with MarketBeat's FREE daily newsletter. Email Address MURA Media Mentions By Week MURA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MURA News Sentiment▼-0.010.38▲Average Medical News Sentiment MURA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MURA Articles This Week▼63▲MURA Articles Average Week Get Mural Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for MURA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Lifevantage News Today C4 Therapeutics News Today Nuvectis Pharma News Today Puma Biotechnology News Today Black Diamond Therapeutics News Today Cellectis News Today Alpha Cognition News Today Molecular Partners News Today Greenwich LifeSciences News Today Nkarta News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MURA) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mural Oncology PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Mural Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
